Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Multiple Sclerosis
|
1022 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1 | 2019 | 2019 | |||||
Malignant Neoplasms
|
1641 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.040 | 0.500 | 4 | 2014 | 2018 | ||||
Primary malignant neoplasm
|
1374 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.040 | 0.500 | 4 | 2014 | 2018 | ||||
Liver carcinoma
|
942 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.020 | 1.000 | 2 | 2015 | 2018 | ||||
Hepatitis B
|
519 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Hypertensive disease
|
1085 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Neural Tube Defects
|
122 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.030 | 1.000 | 3 | 2001 | 2017 | ||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.020 | 1.000 | 2 | 2012 | 2016 | ||||
Parkinson Disease
|
990 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.020 | 1.000 | 2 | 2015 | 2016 | ||||
Breast Carcinoma
|
2793 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.040 | 0.750 | 4 | 2010 | 2015 | ||||
Malignant neoplasm of breast
|
3417 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.040 | 0.750 | 4 | 2010 | 2015 | ||||
Coronary Artery Disease
|
1577 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.020 | 1.000 | 2 | 2013 | 2015 | ||||
Lymphoma, Non-Hodgkin
|
197 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.020 | 1.000 | 2 | 2004 | 2015 | ||||
Adult Non-Hodgkin Lymphoma
|
39 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Adult Solid Neoplasm
|
3 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Childhood Non-Hodgkin Lymphoma
|
39 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Childhood Solid Neoplasm
|
3 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Lymphoma, Non-Hodgkin, Familial
|
79 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Solid Neoplasm
|
24 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Colorectal Carcinoma
|
1962 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.030 | 1.000 | 3 | 2013 | 2014 | ||||
Carcinogenesis
|
355 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.020 | 1.000 | 2 | 2007 | 2014 | ||||
Childhood Leukemia
|
140 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1 | 2014 | 2014 | |||||
Head and Neck Carcinoma
|
118 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1 | 2014 | 2014 | |||||
Laryngeal Diseases
|
7 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1 | 2014 | 2014 | |||||
Laryngeal neoplasm
|
1 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2014 | 2014 |